Back |
home / stock / cyth / cyth message board
Subject | By | Source | When |
---|---|---|---|
I think he meant CLTH. | fwayneh1 | investorshub | 11/02/2008 7:18:09 PM |
you should fix that | thee trader | investorshub | 10/31/2008 10:26:55 PM |
CYTH is the incorrect symbol | thee trader | investorshub | 10/31/2008 10:26:31 PM |
Is CYTH the right symbol? nothing comes up | pay in cash | investorshub | 10/31/2008 7:07:33 PM |
Biodiesel and Ethanol Investing Biomass | tradrdad45 | investorshub | 10/31/2008 4:25:31 PM |
This company is on the forefront of the | tradrdad45 | investorshub | 10/31/2008 3:37:05 PM |
CleanTech BioFuels licensed technology | tradrdad45 | investorshub | 10/30/2008 9:07:42 PM |
CleanTech BioFuels management | tradrdad45 | investorshub | 10/30/2008 8:56:15 PM |
QualityStocks just came out with a nice report | tradrdad45 | investorshub | 10/30/2008 8:51:43 PM |
Greetings IHubbers! | tradrdad45 | investorshub | 10/30/2008 8:33:09 PM |
News, Short Squeeze, Breakout and More Instantly...
Cyclo Therapeutics Inc. Company Name:
CYTH Stock Symbol:
NASDAQ Market:
Cyclo Therapeutics Inc. Website:
Cyclo Therapeutics, Inc. (Nasdaq: CYTH) (“Cyclo Therapeutics” or the “Company”), a clinical stage biotechnology company dedicated to developing life-changing medicines through science and innovation for patients and families living with diseases, today announced that...
NEWARK, N.J., June 14, 2024 (GLOBE NEWSWIRE) -- Rafael Holdings, Inc. (NYSE: RFL), today reported its financial results for the third quarter and the first nine months of fiscal 2024 ended April 30, 2024. “During fiscal 2024, we have continued to develop our existing portfolio while ...
TransportNPC™ is the most comprehensive ongoing controlled pivotal study regarding patient size, global footprint, duration and clinical outcomes for the treatment of Niemann-Pick Disease Type C1 (NPC1) Topline data from the 48-week interim analysis of 104 enrolled patients is anti...